Related Experiment Videos
A trial of continuous-infusion vinblastine in refractory endometrial adenocarcinoma
Gynecologic Oncology
|February 1, 1987
Abstract:
Fourteen patients with refractory or metastatic adenocarcinoma of the endometrium were treated with continuous infusion vinblastine. No patient had a response. One patient had stable disease. Although well tolerated, vinblastine sulfate given by this method has no activity in this malignancy.